Article info
PDFPaper
Genetics
Clinical obligations and public health programmes: healthcare provider reasoning about managing the incidental results of newborn screening
- Correspondence to Dr F A Miller, 155 College Street, 4th Floor, Toronto, Ontario M5T 3M6, Canada; fiona.miller{at}utoronto.ca
Citation
Clinical obligations and public health programmes: healthcare provider reasoning about managing the incidental results of newborn screening
Publication history
- Received March 17, 2009
- Accepted May 15, 2009
- First published September 30, 2009.
Online issue publication
April 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
BMJ Publishing Group Ltd & Institute of Medical Ethics. All rights reserved.
Other content recommended for you
- Cross-sectional prospective feasibility study of newborn screening for sickle cell anaemia and congenital hypothyroidism in Guyana
- Evaluation of newborn sickle cell screening programme in England: 2010–2016
- Effective screening leads to better outcomes in sickle cell disease
- Enablers and barriers to newborn screening for sickle cell disease in Africa: results from a qualitative study involving programmes in six countries
- Positive screening and carrier results for the England-wide universal newborn sickle cell screening programme by ethnicity and area for 2005–07
- Risk of Invasive Pneumococcal Disease in Children with Sickle Cell Disease in England: A National Observational Cohort Study, 2010–2015
- Stakeholder attitudes towards the role and application of informed consent for newborn bloodspot screening: a study protocol
- Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant haemoglobinopathies in England: screening results for 2005–7
- Management of sickle cell disease
- Neonatal haemoglobinopathy screening in Spain